June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Centene (CNC) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: June 16, 2025 (00:37)
Sector: HealthcareThe share price of Centene Corp. (CNC) now
Analysts predictions
Full report
This Week
|
Bullish | Opinions: 1 (1/0/0) |
Previous Week
|
Neutral | Opinions: 1 |
Two Weeks Ago
|
Neutral | Opinions: Na |
Three Weeks Ago
|
Neutral | Opinions: Na |
Are you interested in Centene Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Centene stock price in 2025, 2026, 2027. How much will one Centene share be worth in 2025 - 2027?
When should I take profit in Centene stock? When should I record a loss on Centene stock? What are analysts' forecasts for Centene stock? What is the future of Centene stock? We forecast Centene stock performance using neural networks based on historical data on Centene stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Centene stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Centene shares. This happens once a day.
Historical and forecast chart of Centene stock
The chart below shows the historical price of Centene stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Centene stock price can be found in the table below.
Long-term forecasts by years.
Centene Corp. Analysts predictions review

Centene's stock performance outlook appears resilient with a moderately bullish trend. The company benefits from effective cost management and acquisition integration, driving margin expansion and market share growth. Regulatory adaptability and macroeconomic tailwinds—such as Medicaid expansion—further support its long-term prospects. However, operational inefficiencies and compliance-related risks may temper enthusiasm, especially in the near term. Strategic initiatives like divestitures and share buybacks demonstrate management's commitment to enhancing shareholder value.

Centene Corporation: Operational Excellence and Margin Management Driving Growth Potential

Centene's consistent operational execution highlights its ability to deliver strong financial results despite external challenges. The author's analysis underscores the company's strategic focus on efficiency improvements and cost control, which positions CNC favorably for sustained margin expansion.
Key Drivers and Impacts
Margin discipline was emphasized as a cornerstone of Centene's growth strategy, with the company's leadership prioritizing stringent cost controls to enhance profitability. This approach is particularly impactful in the current macroeconomic environment, where cost management is critical for maintaining investor confidence and stock resilience.
Additionally, Centene's execution in integrating key acquisitions has bolstered its competitive standing, enabling the company to expand its market share. The seamless integration not only supports revenue growth but also enhances operational synergies, which are expected to deliver cost savings in the near term.
Further value was identified in Centene's ability to adapt to regulatory pressures and healthcare industry dynamics. This adaptability strengthens the company's strategic outlook and mitigates risks that could otherwise dampen investor sentiment.

Centene Corporation: Balancing Operational Risks with Promising Growth Opportunities

Centene's operational challenges, including quality concerns in service delivery and operational inefficiencies, have raised investor caution. These issues could potentially erode consumer trust and lead to increased compliance costs, pressuring near-term financial performance.
Key Financial and Market Dynamics
Despite concerns, Centene's strong fundamentals, such as consistent revenue growth and robust cash flow generation, make it well-positioned for long-term value creation. The company's ability to leverage its scale in managed care markets continues to bolster its competitive edge, particularly in government-sponsored programs like Medicaid.
Macroeconomic tailwinds, including Medicaid expansion and aging demographics, provide a favorable backdrop that could offset short-term operational risks. These factors are likely to support top-line growth and create strategic opportunities for further market penetration.
Centene's aggressive share buyback initiatives highlight management’s confidence in the company’s valuation and future growth. Such capital return strategies enhance shareholder value and act as a potential catalyst for boosting the stock price.

Centene: Navigating Growth in Government-Sponsored Healthcare Markets

Centene's strong position within government-sponsored insurance programs, such as Medicaid and Medicare, cements its role as a market leader in providing cost-effective healthcare coverage. The author's thesis underscores how the company's focus on expanding coverage and improving operational efficiencies is likely to bolster revenue growth, particularly as federal and state governments increase funding for managed care plans.
Emerging Drivers and Risks for Centene's Stock Performance
Another key factor highlighted is Centene's divestiture strategy, aimed at streamlining operations and reducing exposure to lower-margin businesses. By narrowing its focus to high-margin and scalable segments, the company could unlock greater shareholder value, though execution risks in shedding non-core assets warrant close monitoring.
The author also emphasizes Centene's growth outlook tied to demographic trends, especially the aging U.S. population driving higher enrollment in government-sponsored programs. These tailwinds provide a robust foundation for consistent long-term cash flows as Medicare Advantage enrollment rates climb.
However, regulatory risk continues to loom large, with potential changes to reimbursement policies and caps on earnings from healthcare plans posing challenges. While the company has historically navigated policy shifts effectively, heightened political scrutiny of the healthcare sector could pressure sentiment and valuations in the near term.
Centene Corporation (CNC) demonstrates a compelling value proposition driven by its robust revenue growth, underpinned by strong demand within the managed care sector and expanding government-sponsored healthcare programs such as Medicare and Medicaid. This solid revenue foundation positions the company to weather economic variability while capturing share in an increasing healthcare market.
Key Drivers of Centene's Investment Appeal
The company's profitability metrics have strengthened as it continues executing operational efficiencies and cost-management initiatives. These efforts are expected to bolster margins, particularly as scale advantages in key Medicaid markets come to fruition, which will likely translate into enhanced earnings stability over the near term.
Strategic diversification of its healthcare offerings, including specialty services and pharmacy benefits management (PBM), adds a further layer of growth potential. By diversifying revenue streams, Centene mitigates exposure risk from potential regulatory changes, a critical consideration for investors in the healthcare space.
Valuation remains a focal point, with CNC currently trading at a discount to industry peers on a forward P/E basis. This undervaluation may reflect market skepticism regarding government-reimbursement complexities, but it simultaneously presents an opportunity for long-term investors seeking capital appreciation alongside potential dividend growth.
Centene's focus on leveraging its Medicare and Medicaid advantage remains a critical growth driver. The company's strong market presence and ability to secure state contracts provide stability in revenues, while its efforts to expand into under-penetrated regions offer tangible long-term potential. However, challenges with managing costs in value-based care agreements could pressure margins in the near term.
The author emphasizes Centene's strategic initiatives to streamline operations and divest non-core assets, which could unlock shareholder value. These measures reduce complexity while improving cash flow and operational efficiency, setting the stage for enhanced financial performance heading into 2024.
Macroeconomic and Sector-Specific Impacts
Macroeconomic factors, including inflationary pressures and shifts in healthcare spending, may weigh on Centene's ability to manage administrative costs. Yet, with a strong balance sheet and significant contract renewals, the company appears well-positioned to weather short-term headwinds and capitalize on an eventual sector recovery.
Finally, the author suggests Centene's valuation, based on current multiples, remains attractive relative to peer groups. The stock trades at a discount, presenting a potential buying opportunity for investors looking to position themselves ahead of anticipated improvements in profitability and growth for Q3 2024.
Centene Corporation's emphasis on disciplined financial management underpins its resilience in the managed care sector. By maintaining a strong balance sheet and cost efficiency, the company is well-positioned to weather macroeconomic uncertainties, ensuring stable cash flows and shareholder confidence. The author highlights this operational prudence as a core strength, which could limit downside risks to the stock in the near term, despite external pressures.
Operational Dynamics and Competitive Landscape
The company's diversified revenue streams through government-sponsored healthcare programs provide a stable income base and a hedge against cyclical volatility. This strategic breadth, as noted by the author, enhances Centene's competitive moats, albeit with some exposure to regulatory adjustments that may temper immediate growth prospects.
Moreover, its focus on streamlining operations and improving efficiency metrics signals management's commitment to long-term margin expansion. The author suggests this could incrementally support valuation multiples once macro headwinds ease, offering investors a potential medium-term payoff.
However, the ongoing industry-wide cost pressures and regulatory changes present latent challenges. While the author acknowledges these factors, managing them effectively through Centene's conservative financial practices could safeguard its operational continuity and investor trust.
Centene Corporation’s strategic positioning within the managed healthcare industry remains a cornerstone of its ability to capitalize on favorable market dynamics. Analysts highlight the company’s robust Medicaid and Medicare Advantage portfolios, which serve as a critical driver of revenue growth amidst demographic shifts and expanding government healthcare programs.
The company’s cost management strategies, particularly its focus on operational efficiency, are instrumental in preserving margins despite industry pricing pressures. Such measures enhance Centene’s financial resilience and improve profitability outlooks, further supporting its investment appeal.
Expanding in High-Growth Markets
Centene’s targeted expansion into underserved and high-growth markets, both domestically and internationally, strengthens its competitive edge and secures long-term revenue streams. The article underscores the importance of these initiatives in differentiating Centene from its peers in a crowded space.
Regulatory trends also remain a pivotal factor, as favorable policy environments continue to support Centene’s core business segments. The ongoing emphasis on value-based care models by policymakers aligns closely with Centene’s existing capabilities, potentially translating into incremental earnings upside.
Centene Corporation operates as a multinational healthcare company that provides programs and services to underinsured and uninsured individuals in the United States. Its Managed Care segment offers health insurance plans to individuals through government-subsidized programs including Medicaid, the government’s child health insurance program, long-term services and supports, foster families and Medicare-medicaid plans that cover dual-eligible individuals, and programs for the elderly, blind or disabled.
Centene daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jun 17 | 55.81 | 55.03 | 56.05 | 1.87 |
Jun 18 | 56.17 | 55.37 | 56.95 | 2.86 |
Jun 19 | 56.32 | 55.92 | 56.56 | 1.15 |
Jun 20 | 56.18 | 55.49 | 56.94 | 2.61 |
Jun 21 | 56.83 | 56.59 | 57.06 | 0.82 |
Jun 22 | 56.87 | 56.62 | 57.78 | 2.05 |
Jun 23 | 56.90 | 56.33 | 57.33 | 1.78 |
Jun 24 | 56.75 | 56.33 | 57.20 | 1.55 |
Jun 25 | 57.23 | 56.80 | 57.66 | 1.51 |
Jun 26 | 56.49 | 55.95 | 57.18 | 2.20 |
Jun 27 | 56.16 | 55.39 | 56.92 | 2.76 |
Jun 28 | 56.10 | 55.85 | 56.51 | 1.19 |
Jun 29 | 56.67 | 56.13 | 57.36 | 2.20 |
Jun 30 | 57.47 | 56.78 | 58.15 | 2.41 |
Jul 01 | 58.00 | 57.41 | 58.56 | 2.00 |
Jul 02 | 58.37 | 58.04 | 59.05 | 1.75 |
Jul 03 | 59.29 | 58.88 | 60.06 | 1.99 |
Jul 04 | 59.59 | 59.16 | 60.37 | 2.03 |
Jul 05 | 60.06 | 59.76 | 60.75 | 1.67 |
Jul 06 | 58.93 | 58.47 | 59.71 | 2.12 |
Jul 07 | 58.50 | 58.17 | 58.82 | 1.13 |
Jul 08 | 57.44 | 56.70 | 58.14 | 2.53 |
Jul 09 | 57.68 | 57.45 | 57.98 | 0.92 |
Jul 10 | 58.59 | 57.81 | 59.00 | 2.07 |
Jul 11 | 58.99 | 58.68 | 59.58 | 1.53 |
Jul 12 | 60.04 | 59.31 | 60.87 | 2.63 |
Jul 13 | 59.14 | 58.82 | 59.85 | 1.75 |
Jul 14 | 58.24 | 57.61 | 58.88 | 2.20 |
Jul 15 | 57.13 | 56.53 | 57.55 | 1.80 |
Jul 16 | 56.59 | 56.08 | 57.23 | 2.06 |
Centene Daily Price Targets
Centene Stock Forecast 06-17-2025.
Forecast target price for 06-17-2025: $55.81.
Positive dynamics for Centene shares will prevail with possible volatility of 1.832%.
Pessimistic target level: 55.03
Optimistic target level: 56.05
Centene Stock Forecast 06-18-2025.
Forecast target price for 06-18-2025: $56.17.
Positive dynamics for Centene shares will prevail with possible volatility of 2.781%.
Pessimistic target level: 55.37
Optimistic target level: 56.95
Centene Stock Forecast 06-19-2025.
Forecast target price for 06-19-2025: $56.32.
Positive dynamics for Centene shares will prevail with possible volatility of 1.135%.
Pessimistic target level: 55.92
Optimistic target level: 56.56
Centene Stock Forecast 06-20-2025.
Forecast target price for 06-20-2025: $56.18.
Negative dynamics for Centene shares will prevail with possible volatility of 2.545%.
Pessimistic target level: 55.49
Optimistic target level: 56.94
Centene Stock Forecast 06-21-2025.
Forecast target price for 06-21-2025: $56.83.
Positive dynamics for Centene shares will prevail with possible volatility of 0.817%.
Pessimistic target level: 56.59
Optimistic target level: 57.06
Centene Stock Forecast 06-22-2025.
Forecast target price for 06-22-2025: $56.87.
Positive dynamics for Centene shares will prevail with possible volatility of 2.008%.
Pessimistic target level: 56.62
Optimistic target level: 57.78
CNC (CNC) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jul. | 59.51 | 57.84 | 60.89 | 5.00 |
Aug. | 63.60 | 62.03 | 66.96 | 7.37 |
Sep. | 61.93 | 59.05 | 65.44 | 9.77 |
Oct. | 57.47 | 53.97 | 59.17 | 8.78 |
Nov. | 57.42 | 53.75 | 59.76 | 10.07 |
Dec. | 57.24 | 54.22 | 59.76 | 9.27 |
Centene forecast for this year
Centene Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $59.5103. Pessimistic: $57.84. Optimistic: $60.89
Centene Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $63.6046. Pessimistic: $62.03. Optimistic: $66.96
Centene Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $61.9255. Pessimistic: $59.05. Optimistic: $65.44
Centene Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $57.4669. Pessimistic: $53.97. Optimistic: $59.17
Centene Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $57.4209. Pessimistic: $53.75. Optimistic: $59.76
Centene Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $57.2371. Pessimistic: $54.22. Optimistic: $59.76
Centene (CNC) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 57.15 | 53.90 | 60.80 | 11.35 |
Feb | 56.83 | 55.69 | 59.19 | 5.91 |
Mar | 56.42 | 53.71 | 58.22 | 7.75 |
Apr | 55.15 | 52.59 | 58.24 | 9.70 |
May | 51.89 | 50.93 | 54.09 | 5.83 |
Jun | 53.67 | 52.00 | 55.22 | 5.83 |
Jul | 57.79 | 54.28 | 61.35 | 11.53 |
Aug | 56.08 | 53.80 | 59.09 | 8.96 |
Sep | 55.86 | 54.34 | 58.36 | 6.89 |
Oct | 58.90 | 57.53 | 61.91 | 7.08 |
Nov | 62.20 | 59.11 | 65.38 | 9.59 |
Dec | 60.06 | 57.51 | 61.40 | 6.34 |
Centene (CNC) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 61.31 | 59.98 | 64.69 | 7.28 |
Feb | 59.39 | 57.92 | 60.34 | 4.02 |
Mar | 59.68 | 58.29 | 62.40 | 6.58 |
Apr | 60.06 | 56.31 | 62.61 | 10.05 |
May | 57.85 | 54.24 | 59.79 | 9.29 |
Jun | 60.07 | 57.38 | 62.23 | 7.80 |
Jul | 64.73 | 60.59 | 66.91 | 9.44 |
Aug | 66.60 | 64.04 | 70.75 | 9.49 |
Sep | 67.13 | 63.37 | 71.10 | 10.88 |
Oct | 66.86 | 63.97 | 68.09 | 6.05 |
Nov | 64.51 | 62.91 | 66.26 | 5.06 |
Dec | 65.70 | 62.07 | 69.69 | 10.94 |
Centene information and performance
7700 FORSYTH BLVD., ST LOUIS, MO, US
Market capitalization of the Centene Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CNC shares in the company outstanding by the market price of one share.
EBITDA of Centene is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Centene Stock)
Should I Buy Centene Shares in 2025 year?
Does Centene pay dividends?
Which economic sector do Centene's shares belong to?
Which other securities belong to the same sector as Centene's shares?
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.